GENE EDITING-BASED METHOD OF ATTENUATING THE BETA-AMYLOID PATHWAY

摘要

Described herein are CRISPR/Cas9 constructs designed for the C-terminal truncation of human amyloid precursor protein (APP) as well as methods of making and using such a construct.